Home » Feature » Page 13

Feature

Featured posts

NDASA submits comments on DOT proposal to add fentanyl to drug testing panel

Submit your comments by Friday, October 17. NDASA has submitted its comments on the Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Fentanyl to the Department of Transportation's Drug-Testing Panel; Harmonization with...

NDASA Announces 2026 Conferene Keynote Speaker: Dr. Stephen Loyd

The National Drug and Alcohol Screening Association is pleased to welcome nationally respected addiction medical specialist and Director of Drug Policy for the State of West Virginia, Dr. Stephen Loyd, as the keynote speaker at the association's 2026 Conference &...

URGENT Take Action NOW on Rescheduling Marijuana

Safety is on the line as the presidential administration signals a schedule change for marijuana. We must act now to protect our industry and to stand for workplace safety by preserving testing for THC. OUR MESSAGE We are profoundly concerned about the proposed...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts

Alcohol screening safety during COVID-19

Alcohol screening safety during COVID-19

Numerous reports over the spring and summer have suggested that substance use disorders are on the rise as a result of the uncertainty, mental health challenges and isolation that are part and parcel of life during COVID-19. Excessive alcohol consumption is one of the...

Buyer beware: CBD, THC and drug testing

Buyer beware: CBD, THC and drug testing

Is CBD medicine or isn’t it? Is it safe? Can it impact a drug test result? Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. There is a great deal of uncertainty about cannabis and cannabinoid...

The epidemic within the pandemic

The epidemic within the pandemic

Long before the coronavirus arrived in the United States, this country was already struggling with another health crisis: the opioid epidemic. As these two epidemics are colliding, experts fear that people vulnerable to opioid use disorders and those who employ them...

The new normal: How to ensure compliance during COVID-19

The new normal: How to ensure compliance during COVID-19

In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...

SAP Clearinghouse questions & answers

SAP Clearinghouse questions & answers

Since the launching of the new Federal Motor Carrier Safety Administration Drug and Alcohol Clearinghouse in January 2020 many questions have arisen about Clearinghouse processes and procedures. Everyone is committed to making the database work well for all...